COMPOSITIONK-PIO 15 mg TabletsEach Uncoated Tablet Contains:Pioglitazone HCl IP eq. to Pioglitazone15 mg K-PIO 30 mg TabletsEach Uncoated Tablet Contains:Pioglitazone HCl IP eq. to Pioglitazone30 mg INDICATIONSK-PIO is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin-dependent diabetes mellitus, NIDDM). K-PIO is indicated for monotherapy. K-PIO is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet and exercise plus the single agent does not result in adequate glycemic control.DOSAGE AND ADMINISTRATIONOral: The recommended dose for K-PIO is 15-45 mg once daily without regard to meals.
HOW SUPPLIED10 Tablets per strip.